New Zealand Bans Tobacco Sales for Future Generations

Dec.13.2022
New Zealand Bans Tobacco Sales for Future Generations
New Zealand introduces world's strictest anti-smoking law, banning tobacco sales to anyone born after 2009 and reducing nicotine content.

New Zealand has passed the world's strictest anti-smoking law which will prohibit future generations from purchasing tobacco. The new ban on smoking, approved by Parliament on Tuesday, sets an unprecedented standard in the fight against tobacco consumption.


This new law includes a ban on selling tobacco to anyone born on or after January 1st, 2009, with fines of up to 150,000 New Zealand dollars ($95,910 USD). The ban will last for the lifetime of the individual.


This legislation will also decrease the permissible nicotine content in tobacco products and reduce the number of retailers allowed to sell tobacco by 90%.


This legislation has expedited the process of achieving a smoke-free future," said Dr. Ayesha Verrall, Deputy Minister of Health, in a statement.


Thousands of people will live longer and healthier lives while the healthcare system will save $5 billion by not having to treat smoking-related illnesses, such as various types of cancer, heart disease, stroke, and amputation.


By the end of 2023, the number of retailers authorized to sell tobacco will decrease from 6,000 to 600.


New Zealand, one of the countries with the lowest adult smoking rates among the 38 nations in the Organization for Economic Cooperation and Development, is further tightening its anti-smoking laws as part of the government's goal to make the country "smoke-free" by 2025.


Bhutan, which banned cigarette sales in 2010, is set to enact stricter anti-smoking laws.


Over the past decade, the number of adult smokers in New Zealand has decreased by half, lowering to 8%, with 56,000 people quitting smoking last year. According to OECD data, 25% of French adults smoke in 2021.


Verrall stated that this legislation will help reduce the life expectancy gap between Māori and non-Māori citizens, which could be as high as 25% for women.


The ACT New Zealand, with 10 seats out of the total 120 in Parliament, has condemned the law, stating that it will result in the closure of small businesses and force people to resort to the black market.


No one wants to see people smoking, but the reality is that some people are willing to do so. The Labor nanny state ban will cause problems," said Deputy Leader Brooke van Velden.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Fontem Drops Texas Lawsuit and Plans to Refile in D.C. Over FDA Handling of Zone Application
Fontem Drops Texas Lawsuit and Plans to Refile in D.C. Over FDA Handling of Zone Application
Fontem US, the maker and seller of Zone nicotine pouches, has voluntarily dismissed its lawsuit against the U.S. Food and Drug Administration, which it had accused of unfairly delaying its market application.
Mar.25 by 2FIRSTS.ai
Exclusive: Glas says FDA-authorized G2 vape includes age-gating technology
Exclusive: Glas says FDA-authorized G2 vape includes age-gating technology
Glas has confirmed to 2Firsts that its G2 device, which received a FDA Marketing Granted Order (MGO), incorporates age-gating technology. Based on currently public information, this means the FDA has granted an MGO to the first ENDS product confirmed to incorporate age-gating technology, validating 2Firsts’ earlier inference.
Mar.17
Special Report | China’s Two Sessions Revisit Consumption Tax Reform, Tobacco Tax Outlook Draws Attention
Special Report | China’s Two Sessions Revisit Consumption Tax Reform, Tobacco Tax Outlook Draws Attention
China’s 2026 “Two Sessions” again raised the issue of consumption tax reform. As the largest source of consumption tax revenue, the tobacco tax system—its collection stages, tax structure and regional revenue distribution—has re-entered the policy discussion. This article outlines the structure of China’s tobacco consumption tax, past adjustments and key areas of debate, providing international readers with background on one of the country’s most important tax categories.
Special Report
Mar.08
TPB Q4 FY2025 Revenue Rises 29% to $121 Million; Modern Oral Business Up 266% Year Over Year
TPB Q4 FY2025 Revenue Rises 29% to $121 Million; Modern Oral Business Up 266% Year Over Year
Turning Point Brands, a U.S. nicotine and tobacco-related consumer products company, reported its fiscal 2025 fourth-quarter results: quarterly revenue was $121 million, up 29% year over year; adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) was $30 million, up 14%. Net revenue from modern oral nicotine products was $41.3 million, up 266% year over year.
Mar.03 by 2FIRSTS.ai
Russia to Start Extrajudicial Blocking of Sites Selling Tobacco and Nicotine Products Online From March 1
Russia to Start Extrajudicial Blocking of Sites Selling Tobacco and Nicotine Products Online From March 1
Russia will introduce an extrajudicial (non-court) blocking mechanism starting March 1, 2026, allowing authorities to block websites selling tobacco and nicotine-containing products online without a court order. State Duma member Anton Nemkin said the change will place offending sites directly onto the prohibited information registry, speeding up enforcement, reducing the court burden, and increasing platform obligations to proactively monitor content.
Jan.29 by 2FIRSTS.ai
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
After France’s ANSES report on nicotine products and harm reduction, Dr. Xin-an Liu wrote to 2Firsts reassessing the field’s foundations. She argues the debate reveals gaps in evidence on long-term behavioral substitution, addiction pathways and neurobiological impacts, and calls for longitudinal research, integrated behavioral science and neuroimaging, clearer risk assessment and stronger transparency to ensure policy and next-generation product development rest on solid evidence.
Industry Insight
Feb.24